Investigator XD – precision data, connected intelligence
With the option to select from a wide range of healthcare data assets you can create the insight package that suits your business needs. Investigator XD provides the capability to focus in on a specific need, for example on a single disease area, locality, organisation type, group of specialists or decision makers, or to take a higher level view on therapy, region, country, or wider audience segments; the choice is yours.
All of this is delivered via our cloud technology, meaning it’s easier to configure and implement and is accessible to all your internal stakeholders when they need it.
Healthcare data and insights available
Investigator XD enables precision planning, informed by localised market insights and competitive intelligence. Identify target NHS customers and align your value proposition to your customers’ priorities, and importantly, continue to monitor your target market segments for changes so you can optimise your plans as necessary.
Our data and insights include:
Specialty-focused data and insights
Quantitative and qualitative data and insights are precisely tailored to a disease or indication providing a deeper understanding of the disease-specific national and local agenda to inform planning.
Formulary and guidance data and insights
A blend of data and real-world evidence to provide an objective view of drug formulary and guideline status in the context of the competitive landscape by indication. This is connected to decision makers and related documentary insights.
Access our database of more than 450k UK healthcare professionals, including all areas of responsibilities, specialties and places of work (physical and virtual). Available as a whole dataset or as modules.
NHS documents and priorities
Find out what your NHS customers are talking about with access to c200k documents published by the NHS and selected healthcare organisations collated and tagged to allow search for topics and keywords relevant to your business interest.
Specialist share data
Provides in-depth insight on patient treatment (what a drug is prescribed for), market share and competitive landscape for chronic diseases in secondary care and community care.